SCHEMBL6517283

SCHEMBL6517283

CCC(=O)c1ccc2[nH]c(C(=O)O)cc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.59
▸ PIN1 Q13526 1/20 0.59
▸ SMAD3 P84022 1/20 0.57
▸ KDM4E B2RXH2 5/20 0.55
▸ HPGD P15428 5/20 0.55
▸ HSD17B10 Q99714 4/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ LMNA P02545 2/20 0.55
▸ TSHR P16473 2/20 0.55
▸ F7 P08709 1/20 0.55
▸ F3 P13726 1/20 0.55
▸ PDPK1 O15530 1/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ APEX1 P27695 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ SRD5A2 P31213 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ DAO P14920 1/20 0.51
▸ MMP2 P08253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3625932 0.88 HRH3 (0.57) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL3633428 0.84 PIN1 (0.55) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL29415437 0.83 SMAD3 (0.68) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL1842307 0.83 SMAD3 (0.68) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL6517340 0.82 HRH3 (0.78) HRH3KDM4EHPGDHSD17B10ALDH1A1
SCHEMBL1734329 0.82 PIN1 (0.65) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL12453719 0.81 PLG (0.56) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL6518479 0.81 HRH3 (0.80) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL6513774 0.79 PIN1 (0.61) HRH3PIN1SMAD3KDM4EHPGD
SCHEMBL3632014 0.79 MMP2 (0.62) HRH3PIN1SMAD3KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026987-A1 CBI analogues of the duocarmycins and CC-1065 THE SCRIPPS RESEARCH INSTITUTE (US) 2005-02-03 — — US disclosed
WO-2004101767-A2 CBI ANALOGUES OF THE DUOCARMYCINS AND CC-1065 THE SCRIPPS RESEARCH INSTITUTE (US) 2004-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026987-A1 CBI analogues of the duocarmycins and CC-1065 CCNI, SP1, DCK HRH3 1791/4885PIN1 1289/4885SMAD3 2119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback